Efficacy of two dose measles vaccination in a community setting

Indian Pediatrics

Volumn 35, Issue 8, 1998, Pages 723-725

  Phadke, M A ^a   Bhargava, Indra ^b   Dhaigude, P ^c   Bagade, A ^a   Biniwale, M A ^a   Kurlekar, S U ^a  

^a B J MEDICAL COLLEGE   (India)

^b Serum Institute of India Ltd   (India)

^c Air Quality Management Cell   (India)

Author keywords

Community; Measles; Vaccine

Indexed keywords

MEASLES VACCINE;

ARTICLE; CHILD; COMMUNITY CARE; COMPARATIVE STUDY; HUMAN; MAJOR CLINICAL STUDY; MEASLES; MEASLES VACCINATION; PATIENT SELECTION; TREATMENT PLANNING;

CASE-CONTROL STUDIES; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; INCIDENCE; INFANT; MEASLES; MEASLES VACCINE; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS VACCINE; RUBELLA VACCINE; VACCINATION; VACCINES, COMBINED;

EID: 0031853140     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Markovitz LE, Katz SL. Measles vaccine. In: Vaccines, 2nd edn. Eds. Plothin SA, Mortimer EA. Philadelphia, W.B. Saunders and Co 1994; pp 229-276.
2. Jobs TJ, John TJ, Joseph A. Antibody response to measles immunization in India. Bull WHO 1984; 62: 737-741.
3. Dave KH. Efficacy of live measles vaccine in India. Proceedings of the Smith-Kline-RIT symposium on Potency and Efficacy of Vaccine. Manila, Phillippines, 1980.
4. Basu RN. Measles vaccine-feasibility, efficacy and complication rates in a multicentric study. Indian J Pediatr 1984; 51: 139-143.
5. Shaikh N, Raut SK, Bedekar SS, Phadke MA, Banerjee K. Experience with a measles vaccine manufactured in India. Indian Pediatr 1992; 29: 883-887.
6. Phadke MA, Rodrigues JJ, Mehta JM, Ayachit V. Clinical and serological evaluation of live measles vaccine in India. Indian Pediatr 1983; 20: 673-576.
7. Bhargava I, Chhaparwal BC, Phadke MA, Irani SF, Chhaparwal D, Dharje S, Maheshwari CP. Immunogenicity and reactogenicity of indigenously produced MMR vaccine. Indian Pediatr 1995; 32: 983-988.
8. Christensen B, Battiger M. Changes in the immunological patterns against mumps, measles and rubella-A vaccination program studied 3 to 7 years after the introduction of a two dose schedule. Vaccine 1991; 9: 326; 329.
9. Measles Report of the Comittee on Infectious Diseases (The Red Book), 22nd edn. Elk Grove Village, American Academy of Pediatrics, 1991; pp 308-323.